Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-07-12 4:04 pm Purchase | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | Deep Track Capital LP | 32,932,392 5.08% | 32,932,392 (New Position) | View |
| 2024-07-02 4:01 pm Purchase | 13G | Eliem Therapeutics Inc. ELYM | Deep Track Capital LP | 3,904,785 5.85% | 3,904,785 (New Position) | View |
| 2024-05-10 4:00 pm Purchase | 13G | Context Therapeutics Inc. CNTX | Deep Track Capital LP | 7,419,355 9.89% | 7,419,355 (New Position) | View |
| 2024-04-26 4:01 pm Purchase | 13G | Korro Bio Inc. KRRO | Deep Track Capital LP | 714,285 7.7% | 714,285 (New Position) | View |
| 2024-04-26 4:01 pm Purchase | 13G | INOVIO PHARMACEUTICALS INC. INO | Deep Track Capital LP | 2,593,822 9.99% | 2,593,822 (New Position) | View |
| 2024-04-22 4:57 pm Purchase | 13G | Zura Bio Ltd ZURA | Deep Track Capital LP | 6,216,327 9.34% | 2,011,327 (+47.83%) | View |
| 2024-04-12 4:08 pm Purchase | 13G | Guardant Health Inc. GH | Deep Track Capital LP | 7,000,000 5.75% | 7,000,000 (New Position) | View |
| 2024-04-05 4:00 pm Purchase | 13G | Avalo Therapeutics Inc. AVTX | Deep Track Capital LP | 114,775 9.99% | 114,775 (New Position) | View |
| 2024-03-22 4:31 pm Purchase | 13G | Olema Pharmaceuticals Inc. OLMA | Deep Track Capital LP | 3,040,248 5.44% | 3,040,248 (New Position) | View |
| 2024-03-22 4:03 pm Purchase | 13G | REGULUS THERAPEUTICS INC P RGLS | Deep Track Capital LP | 6,888,424 9.99% | 6,888,424 (New Position) | View |
| 2024-03-22 4:02 pm Purchase | 13G | CYBIN INC CYBN | Deep Track Capital LP | 58,139,535 7.65% | 58,139,535 (New Position) | View |
| 2024-03-15 4:08 pm Purchase | 13G | Mind Medicine (MindMed) Inc. MNMD | Deep Track Capital LP | 6,666,667 9.49% | 6,666,667 (New Position) | View |
| 2024-03-08 4:03 pm Purchase | 13G | Pyxis Oncology Inc. PYXS | Deep Track Capital LP | 4,184,100 7.87% | 4,184,100 (New Position) | View |
| 2024-02-23 4:48 pm Purchase | 13G | enGene Holdings Inc. ENGN | Deep Track Capital LP | 2,250,000 5.21% | 2,250,000 (New Position) | View |
| 2024-02-14 11:33 am Sale | 13G | Vigil Neuroscience Inc. VIGL | Deep Track Capital LP | 3,649,726 9.62% | -34,893 (-0.95%) | View |
| 2024-02-14 11:32 am Sale | 13G | 89BIO INC ETNB | Deep Track Capital LP | 2,000,000 2.1% | -2,331,499 (-53.83%) | View |
| 2024-02-14 11:31 am Unchanged | 13G | Ambrx Biopharma Inc. AMAM | Deep Track Capital LP | 3,710,412 5.88% | 0 (Unchanged) | View |
| 2024-02-14 09:02 am Unchanged | 13G | Zura Bio Ltd ZURA | Deep Track Capital LP | 4,205,000 9.29% | 0 (Unchanged) | View |
| 2024-02-14 09:01 am Purchase | 13G | Viridian Therapeutics Inc. VRDN | Deep Track Capital LP | 5,378,997 9.9% | 2,066,023 (+62.36%) | View |
| 2024-02-14 08:59 am Sale | 13G | VALNEVA SE SPONSORED ADS VALN | Deep Track Capital LP | 7,526,807 5.42% | -2,986,458 (-28.41%) | View |